Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hypothesis of First North America Population Updated by Mitochondrial Genome Analysis

By LabMedica International staff writers
Posted on 26 Jul 2010
The first arrival humans of North America from Asia is thought to have occurred approximately 15,000-18,000 years ago, however, estimations of the genetic diversity of the first settlers have remained inaccurate. More...
In a new study, researchers have discovered that the diversity of the first Americans has been considerably underestimated, emphasizing the importance of a detailed sampling for accurate analysis of human migrations.

Evidence suggests that humans first crossed into North America from Asia over a land bridge called Beringia, connecting eastern Siberia and Alaska. Genetic studies have provided clues into the initial lineages that entered North America, differentiating the earliest Native American groups from those that arrived later. However, a precise depiction of the number of initial migratory events and routes has been obscure due to incomplete analysis.

In this new project, published online ahead of print on June 29, 2010, in the journal Genome Research, an international group of researchers coordinated by Dr. Antonio Torroni, of the University of Pavia (Italy), performed a comprehensive mitochondrial genome analysis of a poorly characterized lineage known as C1d. Mitochondrial DNA (mtDNA) is passed down through the maternal lineage, and mtDNA sequence markers are very useful tools for mapping ancestry. Similar to other haplogroups that were among the first to arrive in North America, C1d is distributed throughout the continent, suggesting that it may have been also present in the initial founding populations. However, C1d has not been well represented in earlier genetic studies, and the estimated age of about 7,000 years, much younger than the other founding haplogroups, was in all probability inaccurate.

To resolve these inconsistent lines of evidence, the group sequenced and analyzed 63 C1d mtDNA genomes from throughout the Americas. This high-resolution study not only validated that C1d was one of the founding lineages in North America 15,000-18,000 years ago, but revealed another critical insight. "These first female American founders carried not one but two different C1d genomes,” said Ugo Perego, from the Sorenson Molecular Genealogy Foundation (Salt Lake City, UT, USA), and primary author of the study, "thus further increasing the number of recognized maternal lineages from Beringia.”

These study's findings increase the number of founding maternal lineages in North America to 15. Furthermore, this work emphasizes the vital need for a thorough analysis of applicable populations to compile a complete picture of migratory events. Dr. Alessandro Achilli of the University of Perugia (Italy), a coauthor of the report, suggests that the number of distinct mitochondrial genomes that passed from Asian into North America is probably much higher. "These yet undiscovered maternal lineages will be identified within the next three to four years,” Dr. Achilli noted, "when the methodological approach that we used in our study will be systematically applied.”

Scientists involved in the project were from the Sorenson Molecular Genealogy Foundation, the University of Pavia (Pavia, Italy), the University of Perugia (Perugia, Italy), the University of Santiago de Compostela (Santiago de Compostela, Spain), Innsbruck Medical University (Innsbruck, Austria), and the University of Buenos Aries (Buenos Aires, Argentina).

Related Links:

University of Pavia
Sorenson Molecular Genealogy Foundation




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.